Completed PHASE3 INTERVENTIONAL 2-arm NCT02686333

Meditation for Depression and Anxiety Symptoms in Dialysis Patients

Meditation Intervention for the Treatment of Depression and Anxiety Symptoms in Patients Undergoing Dialysis: A Randomized Control Trial

Sponsor: Lady Davis Institute

Conditions Anxiety Depression

Interventions Meditation

Updated 8 times since 2017 Last updated: Sep 8, 2020 Started: Mar 31, 2016 Primary completion: Dec 1, 2017 Completion: Dec 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Anxiety and Depression, this trial is completed. The trial is conducted by Lady Davis Institute and has accumulated 8 data snapshots since 2016. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Oct 2020 — Jan 2021 [monthly]

Completed PHASE3

Status: Unknown Status → Completed
Jul 2019 — Oct 2020 [monthly]

Unknown Status PHASE3

Status: Active Not Recruiting → Unknown Status

▶ Show 3 earlier versions

Jun 2018 — Jul 2019 [monthly]

Active Not Recruiting PHASE3
Jul 2017 — Jun 2018 [monthly]

Active Not Recruiting PHASE3
Jan 2017 — Jul 2017 [monthly]

Active Not Recruiting PHASE3

First recorded

Mar 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lady Davis Institute
Sunnybrook Health Sciences Centre
University Health Network, Toronto

Data source: Lady Davis Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Montreal, Canada